1Hunt S K, Abrahan W T,Chin M H, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Managanent of Chrinic Heart Faihirein the Adult a report of the America Collage of Cardiology/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American college of Chest Physicians and the lnterational Society for Heart and Lung Transplantation endorsed by the heart Rhythm Seciety [J]. Circulation, 2005,112(12) : e154-e235.
4Hamada Y, Tanaka N, Murata K, et al. Significance of predischarge BNP on one-year outcome in decompensated heart failure comparative study with echo-Doppler indexes [J]. J Card Fail, 2005,11 ( 1 ) : 43-49.
5Bast R J, Feeney M, Idzarus H, et al. Reactivity of a monoclonal anti-body with human ovarian carcinoma [J]. Clin Hlvest, 1981,68(5) : 1331-1337.
6Bast Jr R C, Klug T L, St John E, et al. A radioimmuno assay using a monoclonal antibody to monitor the course of epithelial ovarian cancer [Jl. N Engl J Med, 1983,309(15): 883-887.
9Nagele H, Bahlo M, Klapdor R, et al. CA125 and its relation to cardiac function [J]. Am Hear J, 1999,137 (6) : 1044-1049.
10Kouris N T, Zacharor I D, Kontogianni D D, et al. The significance of CA125 levels in patients with chronic congestive heart failure Correlation with clinical and echocardio graphic parameters [J]. Eur J Heart Fail, 2005,7(2) : 199-203.
4Keulenaer G, Brutsaert D. Pathogenesis of heart failure changing conceptual paradigms. Acta Cardiol,1998,53:131-141.
5The Criteria Committee of New York Heart Association. 1994 revisions to classification of functional capacity and objective assessment of patients with disease of the heart. Circulation, 1994,90:644-645.
6Nagele H, Marlies Bahol, Rainer Klapdor, et al. CA125 and its relation to cardiac function. Am Heart J, 1999,137 : 1044-1049.
7Deleeuw PW,kroon AA. Hypertersion and the development of heart failure. Cardiovasc Pharmacol, 1998,32:9-15.
8Drapkin R,Hecht J L.The origins of ovarian cancer:hurdles and progress[J].Women's Oncol Rev,2002,2(2):261-268.
9Jernal A,Murray T,Samuels A,et al.Cancer statistics[J].CA Cancer J Clin,2003,53(1):5-26.
10Whitehouse C,Solomon E.Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening[J].Gynecol Oncol,2003,88(1 Pt 2):152-157.
2Aoka Y, Hagiwara N, Kasanuki H, et al.Heterogeneity of he- modynamic parameters in untreated primary hypertension, and individualization of antihypertensive therapy based on noninvasive hemodynamic measurements [ J ]. Clinical and Ex- perimental Hypertension,2013,35(1) :6! ~66.
3Coogan J S, Humphrey J D, Figueroa C A, et al.Computation- al simulations of hemodynamic changes within thoracic, coro-nary and cerebral arteries following early wall remodeling in response to distal aortic coarctation [ J ]. Biomechanics and Modeling in Mechanobiology,2013,12( 1 ) :79~93.
